Electric pulses + chemo: new hope for vulvar cancer?

NCT ID NCT07443475

Recruiting now Disease control Sponsor: Institute of Oncology Ljubljana Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a treatment called electrochemotherapy for women whose vulvar cancer has come back. It combines a chemotherapy drug (bleomycin) with electric pulses to help the drug enter cancer cells more effectively. The goal is to shrink tumors and avoid major surgery. Only 13 participants will be enrolled in this early-phase trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bleomycin
What this could lead to: If successful, this approach could shrink vulvar cancer tumors and reduce the need for disfiguring surgery, improving quality of life.
What could go wrong: This is a very small early-phase trial (13 people) with no control group, so results may not apply broadly. Side effects from bleomycin or the electric pulses are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT VULVAR CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vulva cancer vulvar carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECURRENT VULVAR CANCER VULVAR CANCER

Contacts and locations

Locations

Institute of Oncology Ljubljana
RECRUITING

Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.